Although collectively these studies provide evidence that 2-HG driven changes to the chromatin architecture are important for oncogenesis, few studies have directly correlated mutant-IDH driven changes of the histone methylome with gene expression in AML and, to date, no studies have examined the histone methylation patterns in IDH-mutant AML patient samples. Here, IDH2 is linked to acute myeloid leukemia.